Cell cycle checkpoint status in human malignant mesothelioma cell lines: Response to gamma radiation

British Journal of Cancer

Volumn 88, Issue 3, 2003, Pages 388-395

  Vivo, C ^a   Lecomte, C ^a   Levy, F ^a   Leroy, K ^b   Kirova, Y ^b   Renier, A ^a   Kheuang, L ^a   Piedbois, P ^b   Chopin, D ^a   Jaurand, M C ^a  

^a FACULTÉ DE MÉDECINE   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

radiation; Cell cycle arrest; Mesothelioma cells

Indexed keywords

PROTEIN P21; PROTEIN P27; PROTEIN P53;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CELL CYCLE; CELL CYCLE G1 PHASE; CELL HETEROGENEITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FLOW CYTOMETRY; GAMMA RADIATION; GENE MUTATION; HUMAN; HUMAN CELL; MALIGNANT MESOTHELIOMA; MISSENSE MUTATION; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIMIAN VIRUS 40;

CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GAMMA RAYS; GENES, CDC; HUMANS; MESOTHELIOMA; MUTATION; SIMIAN VIRUS 40; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037428755     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600736     Document Type: Article

References (35)

1. Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR (1998) The p53 network. J Biol Chem 273: 1-4
2. Ashcroft M, Taya Y, Vousden KH (2000) Stress signals utilize multiple pathways to stabilize p53. Mol Cell Biol 20: 3224-3233
3. Banaei A, Auvert B, Goldberg M, Gueguen A, Luce D, Goldberg S (2000) Future trends in mortality of French men from mesothelioma. Occup Environ Med 57: 488-494
4. Blagosklonny MV, Pardee AB (2001) Exploiting cancer cell cycling for selective protection of normal cells. Cancer Res 61: 4301-4305
5. Blattner C, Hay T, Meek DW, Lane DP (2002) Hypophosphorylation of Mdm2 augments p53 stability. Mol Cell Biol 22: 6170-6182
6. Buard A, Vivo C, Monnet I, Boutin C, Pilatte Y, Jaurand MC (1998) Human malignant mesothelioma cell growth: activation of janus kinase 2 and signal transducer and activator of transcription 1alpha for inhibition by interferon gamma. Cancer Res 58: 840-847
7. 2 arrest after DNA damage. Science 282: 1497-1500
8. Bunz F, Hwang PM, Torrance C, Waldman T, Zhang Y, Dillehay L, Williams J, Lengauer C, Kinzler KW, Volgelstein B (1999) Disruption of p53 in human cancer cells alters responses to therapeutic agents. Lab Invest 104: 263-269
9. Cao X, Mohuiddin I, Ece F, McConkey D, Smythe W (2001) Histone deacetylase inhibitor down-regulation of bcl-x1 gene expression leads to apoptotic cell death in mesothelioma. Am J Respir Cell Mol Biol 25: 562-568
10. Carbone M, Pass HI, Rizzo P, Marinetti M, Di Muzio M, Mew DJY, Levine AS, Procopio A (1994) Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 9: 1781-1790
11. Desdouets C, Brechot C (2000) p27: a pleiotropic regulator of cellular phenotype and a target for cell cycle dysregulation in cancer. Path Biol 48: 203-210
12. Fleury-Feith J, Kheuang L, Zeng L, Bignon J, Boutin C, Monnet I, Jaurand MC (1995) Human malignant mesothelioma cells: variability of ultrastructural features in established and nude mice transplanted cell lines. J Pathol 177: 209-215
13. Giuliano M, Catalano A, Strizzi L, Vianale G, Capogrossi M, Procopio A (2000) Adenovirus-mediated wild-type p53 overexpression reverts tumourigenicity of human mesothelloma cells. Int J Mol Med 5: 591-596
14. Greenblatt MS, Bennett WP, Hollstein M, Harriss CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878
15. Hartwell LH, Kastan MB (1994) Cell cycle control and cancer. Science 266: 1821-1828
16. Karp JE, Broder S (1994) New directions in molecular medicine. Cancer Res 54: 653-665
17. Kazachkov Y, Khaoustov V, Yofe B, Solomon H, Klintmalm GBG, Tabor E (1996) p53 abnormalities in hepatocellular carcinoma from United States patients: analysis of all 11 exons. Carcinogenesis 17: 2207-2212
18. Liu W, Bodle E, Chen JY, Gao M, Rosen GD, Broaddus VC (2001) Tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy cooperate to induce apoptosis in mesothelioma cell lines. Am J Respir Cell Mol Biol 25: 111-118
19. May P, May E (1999) Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18: 7621-7636
20. Mohiuddin I, Cao X, Fang B, Nishizaki M, Smythe WR (2001) Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-x1 down-regulation in mesothelioma. Cancer Gene Ther 8: 547-554
21. Murthy SS, Testa JR (1999) Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma. J Cell Physiol 180: 150-157
22. + human tumor cells synchronized by mitotic selection. Cancer Res 58: 2036-2041
23. Olivier M, Eeles R, Hallstein M, Khan MA, Harris CC, Hainaut P (2002) The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 19: 607-614
24. Oren M, Damalas A, Gottlieb T, Michael D, Taplick J, Martinez Leal JF, Maya R, Moas M, Seger R, Taya Y, Ben-Ze'ev A (2002) Regulation of p53: intricate loops and delicate balances. Biochem Pharmacol 64: 865-871
25. Peto J, Decarli A, La Vecchia C, Levi F, Negri E (1999) The European mesothelioma epidemic. Br J Cancer 79: 667-672
26. Pilatte Y, Vivo C, Renier A, Kheuang L, Greffard A, Jaurand MC (2000) Absence of SV40 large T antigen expression in human mesothelioma cell lines. Am J Respir Cell Mol Biol 23: 788-793
27. Shah MA, Schwartz GK (2001) Cell cycle-mediated drug resistance: an emerging concept in cancer therapy. Clin Cancer Res 8: 2168-2181
28. Strickler HD, Goedert JJ, Fleming M, Travis WD, Williams AE, Rabkin CS, Daniel RW, Shah KV (1996) Simian virus 40 and pleural mesothelioma in humans. Cancer Epidemiol Biomark Prev 5: 473-475
29. Testa JR, Giordano A (2001) SV40 and cell cycle perturbations in malignant mesothelioma. Semin Cancer Biol 11: 31-38
30. Vivo C, Levy F, Pilatte Y, Fleury-Feith J, Chretien P, Monnet I, Kheuang L, Jaurand MC (2001) Control of cell cycle progression in human mesothelioma cells treated with gamma interferon. Oncogene 20: 1085-1093
31. Waheed I, Guo ZS, Chen GA, Weiser TS, Nguyen DM, Schrump DS (1999) Antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigen-positive human pleural mesothelioma cells. Cancer Res 53: 6068-6073
32. 1 arrest in human cancer cells. Cancer Res 55: 5187-5190
33. waf1 in tumour response to radiation therapy. Oncogene 18: 6540-6545
34. ARF gene transfer in human mesothelioma cells. J Natl Cancer Inst 92: 636-641
35. Zeng L, Fleury-Feith J, Monnet I, Boutin C, Bignon J, Jaurand MC (1994) Immunocytochemical characterization of cell lines from human malignant mesothelioma-characterization of human mesothelioma cell lines by immunocytochemistry with a panel of monoclonal antibodies. Hum Pathol 25: 227-234